223 related articles for article (PubMed ID: 35015834)
21. Unusual immunophenotype of T-cell large granular lymphocytic leukemia: report of two cases.
Rabade N; Mansukhani D; Khodaiji S; Padte B; Bhave A; Tembhare P; Subramanian PG; Sehgal K
Indian J Pathol Microbiol; 2015; 58(1):108-12. PubMed ID: 25673609
[TBL] [Abstract][Full Text] [Related]
22. Linking the KIR phenotype with STAT3 and TET2 mutations to identify chronic lymphoproliferative disorders of NK cells.
Pastoret C; Desmots F; Drillet G; Le Gallou S; Boulland ML; Thannberger A; Doncker AV; Salaun V; Damaj GL; Veyrat-Masson R; Tournilhac O; Moignet A; Pangault C; Roussel M; Fest T; Lamy T
Blood; 2021 Jun; 137(23):3237-3250. PubMed ID: 33512451
[TBL] [Abstract][Full Text] [Related]
23. Analysis of a single-institution cohort of patients with Felty's syndrome and T-cell large granular lymphocytic leukemia in the setting of rheumatoid arthritis.
Gorodetskiy VR; Sidorova YV; Kupryshina NA; Vasilyev VI; Probatova NA; Ryzhikova NV; Sudarikov AB
Rheumatol Int; 2021 Jan; 41(1):147-156. PubMed ID: 33280072
[TBL] [Abstract][Full Text] [Related]
24. Familial CD3+ T large granular lymphocyte leukemia: evidence that genetic predisposition and antigen selection promote clonal cytotoxic T-cell responses.
Stalika E; Papalexandri A; Iskas M; Stavroyianni N; Kanellis G; Kotta K; Pontikoglou C; Siorenta A; Anagnostopoulos A; Papadaki H; Papadaki T; Stamatopoulos K
Leuk Lymphoma; 2014 Aug; 55(8):1781-7. PubMed ID: 24180333
[TBL] [Abstract][Full Text] [Related]
25. Activating somatic mutations outside the SH2-domain of STAT3 in LGL leukemia.
Andersson E; Kuusanmäki H; Bortoluzzi S; Lagström S; Parsons A; Rajala H; van Adrichem A; Eldfors S; Olson T; Clemente MJ; Laasonen A; Ellonen P; Heckman C; Loughran TP; Maciejewski JP; Mustjoki S
Leukemia; 2016 May; 30(5):1204-8. PubMed ID: 26419508
[No Abstract] [Full Text] [Related]
26. T-cell large granular lymphocytic (LGL) leukemia consists of CD4
Kuwahara N; Kodaka T; Zushi Y; Sasaki M; Goka T; Maruoka H; Aoyama Y; Tsunemine H; Yamane T; Kobayashi J; Kawakami T; Ishida F; Itoh T; Takahashi T
J Clin Exp Hematop; 2019; 59(4):202-206. PubMed ID: 31866622
[TBL] [Abstract][Full Text] [Related]
27. Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia.
Johansson P; Bergmann A; Rahmann S; Wohlers I; Scholtysik R; Przekopowitz M; Seifert M; Tschurtschenthaler G; Webersinke G; Jäger U; Siebert R; Klein-Hitpass L; Dührsen U; Dürig J; Küppers R
Int J Cancer; 2016 Jan; 138(1):121-4. PubMed ID: 26199174
[TBL] [Abstract][Full Text] [Related]
28. Dysregulated signaling, proliferation and apoptosis impact on the pathogenesis of TCRγδ+ T cell large granular lymphocyte leukemia.
Kallemeijn MJ; de Ridder D; Schilperoord-Vermeulen J; van der Klift MY; Sandberg Y; van Dongen JJ; Langerak AW
PLoS One; 2017; 12(4):e0175670. PubMed ID: 28407008
[TBL] [Abstract][Full Text] [Related]
29. Donor-Derived T-Cell Large Granular Lymphocytic Leukemia in a Patient With Peripheral T-Cell Lymphoma.
Hidalgo Lopez JE; Yabe M; Carballo-Zarate AA; Wang SA; Jorgensen JL; Ahmed S; Lee J; Li S; Schlette E; McDonnell T; Miranda RN; Medeiros LJ; Bueso-Ramos CE; Yin CC
J Natl Compr Canc Netw; 2016 Aug; 14(8):939-44. PubMed ID: 27496109
[TBL] [Abstract][Full Text] [Related]
30. [Large Granular Lymphocytic Leukemia and JAK/STAT Signaling Pathway--Review].
Qiu ZY; Fan Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Feb; 24(1):254-60. PubMed ID: 26913432
[TBL] [Abstract][Full Text] [Related]
31. Mutations in the signal transducer and activator of transcription family of genes in cancer.
Shahmarvand N; Nagy A; Shahryari J; Ohgami RS
Cancer Sci; 2018 Apr; 109(4):926-933. PubMed ID: 29417693
[TBL] [Abstract][Full Text] [Related]
32. Concurrent STAT3, DNMT3A, and TET2 mutations in T-LGL leukemia with molecularly distinct clonal hematopoiesis of indeterminate potential.
Raess PW; Cascio MJ; Fan G; Press R; Druker BJ; Brewer D; Spurgeon SE
Am J Hematol; 2017 Jan; 92(1):E6-E8. PubMed ID: 27761930
[No Abstract] [Full Text] [Related]
33.
Muñoz-García N; Jara-Acevedo M; Caldas C; Bárcena P; López A; Puig N; Alcoceba M; Fernández P; Villamor N; Flores-Montero JA; Gómez K; Lemes MA; Hernández JC; Álvarez-Twose I; Guerra JL; González M; Orfao A; Almeida J
Cancers (Basel); 2020 Nov; 12(12):. PubMed ID: 33255665
[No Abstract] [Full Text] [Related]
34. [Clinical characteristics of T-cell large granular lymphoblastic leukemia with STAT3 gene mutation].
Liu HL; Cao L; Zhao XL; Guo JJ; Qiao C; Zhu HY; Wang L; Xu W; Li JY; Fan L
Zhonghua Xue Ye Xue Za Zhi; 2021 Jun; 42(6):495-501. PubMed ID: 34384156
[No Abstract] [Full Text] [Related]
35. Clinicopathologic, Immunophenotypic, Cytogenetic, and Molecular Features of γδ T-Cell Large Granular Lymphocytic Leukemia: An Analysis of 14 Patients Suggests Biologic Differences With αβ T-Cell Large Granular Lymphocytic Leukemia. [corrected].
Yabe M; Medeiros LJ; Wang SA; Konoplev S; Ok CY; Loghavi S; Lu G; Flores L; Khoury JD; Cason RC; Young KH; Miranda RN
Am J Clin Pathol; 2015 Oct; 144(4):607-19. PubMed ID: 26386082
[TBL] [Abstract][Full Text] [Related]
36. Novel somatic mutations in large granular lymphocytic leukemia affecting the STAT-pathway and T-cell activation.
Andersson EI; Rajala HL; Eldfors S; Ellonen P; Olson T; Jerez A; Clemente MJ; Kallioniemi O; Porkka K; Heckman C; Loughran TP; Maciejewski JP; Mustjoki S
Blood Cancer J; 2013 Dec; 3(12):e168. PubMed ID: 24317090
[TBL] [Abstract][Full Text] [Related]
37.
Teramo A; Barilà G; Calabretto G; Ercolin C; Lamy T; Moignet A; Roussel M; Pastoret C; Leoncin M; Gattazzo C; Cabrelle A; Boscaro E; Teolato S; Pagnin E; Berno T; De March E; Facco M; Piazza F; Trentin L; Semenzato G; Zambello R
Oncotarget; 2017 Sep; 8(37):61876-61889. PubMed ID: 28977911
[No Abstract] [Full Text] [Related]
38. STAT3 gain-of-function mutations connect leukemia with autoimmune disease by pathological NKG2D
Masle-Farquhar E; Jackson KJL; Peters TJ; Al-Eryani G; Singh M; Payne KJ; Rao G; Avery DT; Apps G; Kingham J; Jara CJ; Skvortsova K; Swarbrick A; Ma CS; Suan D; Uzel G; Chua I; Leiding JW; Heiskanen K; Preece K; Kainulainen L; O'Sullivan M; Cooper MA; Seppänen MRJ; Mustjoki S; Brothers S; Vogel TP; Brink R; Tangye SG; Reed JH; Goodnow CC
Immunity; 2022 Dec; 55(12):2386-2404.e8. PubMed ID: 36446385
[TBL] [Abstract][Full Text] [Related]
39. Subclonal STAT3 mutations solidify clonal dominance.
Kerr CM; Clemente MJ; Chomczynski PW; Przychodzen B; Nagata Y; Adema V; Visconte V; Lichtin AE; Mustjoki S; Radivoyevitch T; Sekeres MA; Maciejewski JP
Blood Adv; 2019 Mar; 3(6):917-921. PubMed ID: 30898763
[TBL] [Abstract][Full Text] [Related]
40. Stat3 mutations impact on overall survival in large granular lymphocyte leukemia: a single-center experience of 205 patients.
Barilà G; Teramo A; Calabretto G; Vicenzetto C; Gasparini VR; Pavan L; Leoncin M; Vedovato S; Frigo AC; Facco M; Semenzato G; Zambello R
Leukemia; 2020 Apr; 34(4):1116-1124. PubMed ID: 31740810
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
